Arunachala Murthy Tejaswini, Chapman Marianne, Jones Karen L, Horowitz Michael, Marathe Chinmay S
Adelaide Medical School, University of Adelaide, Adelaide 5000, SA, Australia.
Intensive Care Unit, Royal Adelaide Hospital, Adelaide 5000, SA, Australia.
World J Diabetes. 2023 May 15;14(5):447-459. doi: 10.4239/wjd.v14.i5.447.
Gastric emptying (GE) exhibits a wide inter-individual variation and is a major determinant of postprandial glycaemia in health and diabetes; the rise in blood glucose following oral carbohydrate is greater when GE is relatively more rapid and more sustained when glucose tolerance is impaired. Conversely, GE is influenced by the acute glycaemic environment acute hyperglycaemia slows, while acute hypoglycaemia accelerates it. Delayed GE (gastroparesis) occurs frequently in diabetes and critical illness. In diabetes, this poses challenges for management, particularly in hospitalised individuals and/or those using insulin. In critical illness it compromises the delivery of nutrition and increases the risk of regurgitation and aspiration with consequent lung dysfunction and ventilator dependence. Substantial advances in knowledge relating to GE, which is now recognised as a major determinant of the magnitude of the rise in blood glucose after a meal in both health and diabetes and, the impact of acute glycaemic environment on the rate of GE have been made and the use of gut-based therapies such as glucagon-like peptide-1 receptor agonists, which may profoundly impact GE, in the management of type 2 diabetes, has become commonplace. This necessitates an increased understanding of the complex inter-relationships of GE with glycaemia, its implications in hospitalised patients and the relevance of dysglycaemia and its management, particularly in critical illness. Current approaches to management of gastroparesis to achieve more personalised diabetes care, relevant to clinical practice, is detailed. Further studies focusing on the interactions of medications affecting GE and the glycaemic environment in hospitalised patients, are required.
胃排空(GE)存在广泛的个体差异,并且是健康人群和糖尿病患者餐后血糖的主要决定因素;当胃排空相对较快时,口服碳水化合物后血糖升高幅度更大,而当糖耐量受损时,血糖升高更持久。相反,胃排空受急性血糖环境的影响——急性高血糖会使其减慢,而急性低血糖则会加速胃排空。胃排空延迟(胃轻瘫)在糖尿病和危重症中经常发生。在糖尿病中,这给治疗带来了挑战,尤其是在住院患者和/或使用胰岛素的患者中。在危重症中,它会影响营养物质的输送,并增加反流和误吸的风险,进而导致肺功能障碍和呼吸机依赖。在胃排空方面已经取得了重大进展,胃排空现在被认为是健康人群和糖尿病患者餐后血糖升高幅度的主要决定因素,并且急性血糖环境对胃排空速率的影响也已明确,在2型糖尿病的治疗中,使用如胰高血糖素样肽-1受体激动剂等基于肠道的疗法(可能会对胃排空产生深远影响)已变得很普遍。这就需要更多地了解胃排空与血糖之间复杂的相互关系、其在住院患者中的意义以及血糖异常及其管理的相关性,尤其是在危重症中。本文详细阐述了目前用于实现更个性化糖尿病护理的胃轻瘫管理方法,这些方法与临床实践相关。还需要进一步开展研究,关注影响住院患者胃排空的药物与血糖环境之间的相互作用。